Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying the side effects and how well giving tipifarnib
together with etoposide works in treating older patients with newly diagnosed, previously
untreated acute myeloid leukemia. Tipifarnib may stop the growth of cancer cells by blocking
some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as etoposide,
work in different ways to stop the growth of cancer cells, either by killing the cells or by
stopping them from dividing. Giving tipifarnib together with etoposide may kill more cancer
cells.